Author: Bella Hayes
TROPION-Lung12 Phase 3 Trial Initiated Evaluating DATROWAY ® as Part of Adjuvant Regimen for Patients with Early-Stage Non-Small Cell Lung Cancer at High Risk of Relapse Source link
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PCRX Source link
SYM DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Symbotic Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 3 Deadline in Securities Class Action First Source link
AEHR DEADLINE ALERT: ROSEN, HIGHLY-RANKED INVESTOR COUNSEL, Encourages Aehr Test Systems Investors with Losses in Excess of $100K to Secure Counsel Before Important February 3 Deadline in Securities C Source link
ASPI DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ASP Isotopes Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 3 Deadline in Securities Class Action Source link
Block, Inc. (XYZ) Faces Securities Class Action, Regulators Levy Cash App Fines Following Investigations Going Back to Hindenburg Report- Hagens Berman Source link
Naas Technology Inc. Completes China's First Carbon Emission Reduction Credit Transaction in EV Charging Space, Pioneering Opportunities in Sustainable Mobility Source link
Lundbeck announces positive results from 12-month Open-Label Extension (OLE) of the PACIFIC trial evaluating bexicaserin in participants with Developmental and Epileptic Encephalopathies Source link
Galderma Demonstrates Injectable Aesthetics Leadership in Medication-Driven Weight Loss With New Research and First International Consensus-Based Guidelines Source link
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Sun Communities, Inc. Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action – SUI Source link
